Search Results

You are looking at 1 - 5 of 5 items for

  • Author or Editor: Lowell Midla x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective

To evaluate, in primiparous cows, the effect of dietary biotin supplementation on severity of lesions of aseptic subclinical laminitis.

Animals

100 primiparous cows in a 800-cow commercial dairy herd.

Procedure

Cows were assigned after calving to a biotin-supplemented (20 mg/head/d) or control group on an alternating basis. Digits 3 and 4 of the left forelimb and right hind limb were examined at a mean of 25, 108, and 293 days after parturition. Toe length, hoof angle, and heel depth were measured, and hooves were examined for solear hemorrhage, yellow solear discoloration, separation of the white line, and heel erosion. Serum and milk biotin concentrations were also measured.

Results

Serum biotin concentrations were significantly higher for supplemented than for control cows. During the second examination, prevalence of separation of the white line of digits 3 and 4 of the hind limb and digit 4 of the forelimb was lower for supplemented than for control cows. Mean decrease in heel depth between the first and third examinations was approximately twice as great for digit 4 of the forelimb and 4 times as great for digit 3 of the forelimb in supplemented, versus control, cows. Other differences were not found.

Conclusions and Clinical Relevance

Results suggest that supplemental dietary biotin may have a beneficial effect on hoof health in intensively managed primiparous dairy cows. (Am J Vet Res 1998;59:733-738)

Free access
in American Journal of Veterinary Research

Abstract

OBJECTIVE

Compare immune responses induced by 2 commercial intranasal (IN) modified-live viral (MLV) vaccines given individually or coadministered and evaluate prevention of infection and lung pathology following bovine herpesvirus-1 (BHV-1) challenge.

ANIMALS

36 male Holstein calves (ages, 5 to 12 days).

METHODS

In a randomized complete block design, each calf received an IN injection of either vaccine diluent (Placebo), an MLV vaccine containing bovine herpesvirus-1 (BHV-1; N3), bovine coronavirus vaccine (BC), or both N3 and BC (BC + N3) with a booster 4 weeks later. Nasal secretions and blood were collected weekly. Three weeks after the booster, the calves were challenged with BHV-1, sampled for virus shedding, and euthanized 10 days later to quantify lung pathology. The study period was September 7, 2020, to April 6, 2021.

RESULTS

Calves were seropositive for BHV-1 and BC before vaccination. No significant difference in BC-specific serum immunoglobin G and nasal immunoglobin A antibody responses in the BC versus BC + N3 group or BHV-1–specific serum immunoglobin G and nasal immunoglobin A antibody responses in the N3 versus BC + N3 group. Cytokine responses to BHV-1 and BC did not differ among groups. BHV-1 shedding after challenge was significantly reduced in N3 groups versus Placebo and BC. There was a significant reduction in lung pathology in the N3 + BC group versus Placebo.

CLINICAL RELEVANCE

This study provides evidence an MLV vaccine containing BHV-1 and an MLV BC vaccine can be coadministered to neonatal calves without significantly altering immune responses to the 2 viruses or compromising the prevention of BHV-1 respiratory disease. Calves receiving the BC + N3 vaccine had a significant reduction in lung pathology after BHV-1 aerosol challenge.

Open access
in American Journal of Veterinary Research

Abstract

OBJECTIVE

To compare immune responses induced by 2 commercially available vaccines with a bovine herpesvirus type 1 (BHV1) component following intranasal (IN) administration to colostrum-fed calves.

ANIMALS

90 male Holstein calves (ages, 5 to 14 days).

PROCEDURES

In a randomized complete block design, each calf received 2 mL (1 mL/nostril) of vaccine A (n = 30), vaccine B (30), or saline (0.9% NaCl) solution (30) on day 0. Blood samples were collected for determination of serum anti-BHV1 IgG titer, and nasal fluid (NF) samples were collected for determination of interferon (IFN)-α and IFN-γ concentrations and for secretory IgA titers against BHV1, Mannheimia haemolytica, and Pasteurella multocida at predetermined times for 42 days after vaccination.

RESULTS

All calves were seropositive for anti-BHV1 IgG, and the mean anti-BHV1 IgG titer did not differ significantly among the 3 groups at any time. Both vaccines induced significant transient increases in NF IFN-α and IFN-γ concentrations. On day 5, mean IFN-α concentration and the proportion of calves with detectable IFN-α concentrations for the vaccine A group were significantly greater than those for the vaccine B and control groups. On day 42, the mean NF anti–P multocida IgA titers for both vaccine groups were significantly greater than that of the control group.

CONCLUSIONS AND CLINICAL RELEVANCE

Both vaccines induced innate and acquired immune responses in calves with colostral antibodies. The magnitude of the IFN-α response and proportion of calves with detectable IFN-α differed between the 2 vaccine groups. Both vaccines appeared to enhance the IgA response against P multocida.

Full access
in Journal of the American Veterinary Medical Association